HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nora D Volkow Selected Research

Cocaine (Cocaine HCl)

12/2014Ultrasensitive detection of 3D cerebral microvascular network dynamics in vivo.
11/2012Psychophysiological prediction of choice: relevance to insight and drug addiction.
1/2012PET imaging predicts future body weight and cocaine preference.
3/2011Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.
12/2010Chronic forced exercise during adolescence decreases cocaine conditioned place preference in Lewis rats.
12/2010Obesity-resistant S5B rats showed greater cocaine conditioned place preference than the obesity-prone OM rats.
5/2010Impaired insight in cocaine addiction: laboratory evidence and effects on cocaine-seeking behaviour.
7/2009Enhanced choice for viewing cocaine pictures in cocaine addiction.
4/2009The neuropsychology of cocaine addiction: recent cocaine use masks impairment.
1/2009The effect of intravenous lidocaine on brain activation during non-noxious and acute noxious stimulation of the forepaw: a functional magnetic resonance imaging study in the rat.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Nora D Volkow Research Topics

Disease

22Obesity
06/2014 - 10/2002
15Substance-Related Disorders (Drug Abuse)
04/2015 - 11/2002
15Cocaine-Related Disorders (Cocaine Addiction)
03/2014 - 04/2003
13Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2014 - 03/2002
5Pain (Aches)
02/2015 - 02/2006
4Hyperphagia
01/2014 - 09/2008
4Body Weight (Weight, Body)
01/2012 - 11/2005
3Parkinson Disease (Parkinson's Disease)
11/2015 - 02/2015
3Alcoholism (Alcohol Abuse)
03/2013 - 05/2012
3Sleep Deprivation
05/2012 - 08/2008
2Neoplasms (Cancer)
12/2014 - 10/2013
2Brain Diseases (Brain Disorder)
07/2014 - 05/2012
2Insulin Resistance
08/2013 - 01/2009
2Glucose Intolerance
08/2013 - 01/2009
2Weight Gain
04/2013 - 01/2012
2Binge-Eating Disorder (Binge Eating Disorder)
06/2012 - 08/2011
2Dementia (Dementias)
08/2008 - 11/2004
1Postoperative Pain
02/2015
1Weight Loss (Weight Reduction)
01/2015
1Brain Neoplasms (Brain Tumor)
12/2014
1Ischemia
12/2014
1Hypercapnia
10/2014
1Psychomotor Agitation (Akathisia)
07/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
06/2014
1Opioid-Related Disorders (Opiate Addiction)
12/2013
1Morbid Obesity
12/2012
1Atrophy
05/2012
1Alcohol-Related Disorders
01/2012
1HIV Infections (HIV Infection)
09/2011
1Bulimia (Binge Eating)
08/2011
1Nervous System Diseases (Neurological Disorders)
01/2011
1Tuberculosis (Tuberculoses)
01/2010
1Infection
01/2010
1Pulmonary Hypertension (Ayerza Syndrome)
01/2010
1Narcolepsy
03/2009
1Neuralgia (Stump Neuralgia)
01/2009
1Fatigue
08/2008
1Conduct Disorder
05/2008
1Seizures (Seizure)
11/2006
1Hypotension (Low Blood Pressure)
11/2006
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
06/2006
1Drug Toxicity (Drug Safety)
01/2005
1Alzheimer Disease (Alzheimer's Disease)
02/2002

Drug/Important Bio-Agent (IBA)

34Dopamine (Intropin)FDA LinkGeneric
11/2015 - 10/2002
18Cocaine (Cocaine HCl)IBA
12/2014 - 04/2003
18Methylphenidate (Ritalin)FDA LinkGeneric
03/2014 - 03/2002
6RacloprideIBA
07/2014 - 01/2008
6Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
02/2013 - 01/2008
4LeptinIBA
04/2013 - 09/2008
3Methamphetamine (Desoxyn)FDA LinkGeneric
11/2015 - 02/2008
3Monoamine Oxidase (MAO)IBA
03/2015 - 05/2008
3Glucose (Dextrose)FDA LinkGeneric
06/2014 - 02/2002
3Carbon MonoxideIBA
10/2013 - 02/2008
3Insulin (Novolin)FDA Link
08/2013 - 07/2010
3Opioid Analgesics (Opioids)IBA
04/2011 - 02/2006
3Leptin ReceptorsIBA
01/2009 - 01/2008
2Selegiline (E250)FDA LinkGeneric
02/2015 - 04/2003
23- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)IBA
01/2015 - 12/2010
2Dopamine D3 ReceptorsIBA
08/2014 - 06/2008
2Analgesics (Analgesic Drugs)IBA
10/2013 - 02/2006
2Bromocriptine (Parlodel)FDA LinkGeneric
02/2011 - 01/2009
1Biological Markers (Surrogate Marker)IBA
04/2015
1Endocannabinoids (Endocannabinoid)IBA
02/2015
1Interleukin-6 (Interleukin 6)IBA
02/2015
1Glycerol (Glycerine)FDA LinkGeneric
02/2015
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
12/2014
1Hemoglobins (Hemoglobin)IBA
10/2014
1Histone Deacetylase InhibitorsIBA
07/2014
1Histone Deacetylases (Histone Deacetylase)IBA
07/2014
1GhrelinIBA
06/2014
1preproenkephalinIBA
12/2013
1Butyric Acid (Butanoic Acid)IBA
10/2013
14-phenylbutyric acid (Buphenyl)FDA Link
10/2013
1Fatty Acids (Saturated Fatty Acids)IBA
10/2013
1Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
10/2013
1HormonesIBA
05/2012
1Ethanol (Ethyl Alcohol)IBA
05/2012
1Ghrelin ReceptorsIBA
01/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2012
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2011
1modafinil (armodafinil)FDA Link
03/2009
1Blood Glucose (Blood Sugar)IBA
01/2009
1Lidocaine (Xylocaine)FDA LinkGeneric
01/2009
1Nonesterified Fatty Acids (NEFA)IBA
01/2009
1Triglycerides (Triacylglycerol)IBA
01/2009
1SmokeIBA
05/2008
1NicotineFDA Link
05/2008
1SpiperoneIBA
01/2008
1Amphetamine (Amfetamine)FDA LinkGeneric
10/2007
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
11/2006
1rimonabantIBA
11/2005

Therapy/Procedure

4Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2015 - 01/2012
1Arthroplasty
02/2015
1Highly Active Antiretroviral Therapy (HAART)
09/2011
1Bariatric Surgery
09/2010
1Self Administration (Administration, Self)
06/2008
1Drug Therapy (Chemotherapy)
10/2003